BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 17767461)

  • 1. Review article: yeast as probiotics -- Saccharomyces boulardii.
    Czerucka D; Piche T; Rampal P
    Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
    Kotowska M; Albrecht P; Szajewska H
    Aliment Pharmacol Ther; 2005 Mar; 21(5):583-90. PubMed ID: 15740542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of probiotic Saccharomyces boulardii on prevention of antibiotic-associated diarrhea in adult outpatients with amoxicillin treatment].
    Bravo MV; Bunout D; Leiva L; de la Maza MP; Barrera G; de la Maza J; Hirsch S
    Rev Med Chil; 2008 Aug; 136(8):981-8. PubMed ID: 18949181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study.
    Can M; Beşirbellioglu BA; Avci IY; Beker CM; Pahsa A
    Med Sci Monit; 2006 Apr; 12(4):PI19-22. PubMed ID: 16572062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease.
    McFarland LV
    Am J Gastroenterol; 2006 Apr; 101(4):812-22. PubMed ID: 16635227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics: preventing antibiotic-associated diarrhea.
    Jones K
    J Spec Pediatr Nurs; 2010 Apr; 15(2):160-2. PubMed ID: 20367786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics for prevention and treatment of diarrhea.
    Guandalini S
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S149-53. PubMed ID: 21992955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.
    McFarland LV
    Anaerobe; 2009 Dec; 15(6):274-80. PubMed ID: 19825425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children.
    Szajewska H; Skórka A; Dylag M
    Aliment Pharmacol Ther; 2007 Feb; 25(3):257-64. PubMed ID: 17269987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
    Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
    Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Jul; 41(7):1212-21. PubMed ID: 17595306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics for children with diarrhea: an update.
    Guandalini S
    J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S53-7. PubMed ID: 18520336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diarrhea, and the experimental treatment Saccharomyces boulardii.
    James JS
    AIDS Treat News; 1995 Jun; (no 224):1-4. PubMed ID: 11362510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
    McFarland LV; Surawicz CM; Greenberg RN; Elmer GW; Moyer KA; Melcher SA; Bowen KE; Cox JL
    Am J Gastroenterol; 1995 Mar; 90(3):439-48. PubMed ID: 7872284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccharomyces boulardii in childhood.
    Vandenplas Y; Brunser O; Szajewska H
    Eur J Pediatr; 2009 Mar; 168(3):253-65. PubMed ID: 19096876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical indications for probiotics: an overview.
    Goldin BR; Gorbach SL
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S96-100; discussion S144-51. PubMed ID: 18181732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the causes of negative studies: a case of S boulardii for the prevention of antibiotic-associated diarrhea.
    McFarland LV
    Rev Med Chil; 2009 May; 137(5):719-20. PubMed ID: 19701565
    [No Abstract]   [Full Text] [Related]  

  • 18. Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study.
    Villarruel G; Rubio DM; Lopez F; Cintioni J; Gurevech R; Romero G; Vandenplas Y
    Acta Paediatr; 2007 Apr; 96(4):538-41. PubMed ID: 17306006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
    Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
    Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Saccharomyces boulardii modulates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment].
    Collignon A; Sandré C; Barc MC
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S71-8. PubMed ID: 20889009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.